{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:54:54Z","timestamp":1791143694695,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003718","name":"Korea Institute of Oriental Medicine","doi-asserted-by":"publisher","award":["KSN2512030"],"award-info":[{"award-number":["KSN2512030"]}],"id":[{"id":"10.13039\/501100003718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neulet.2026.138746","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:36:13Z","timestamp":1790750173000},"page":"138746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Varlitinib attenuates neuroinflammation and dopaminergic neurodegeneration in experimental Parkinsonism"],"prefix":"10.1016","volume":"888","author":[{"given":"Hye-Sun","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonhwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8911-831X","authenticated-orcid":false,"given":"Gunhyuk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2026.138746_b0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13041-025-01218-6","article-title":"Neurodegeneration in Parkinson\u2019s disease: are we looking at the right spot?","volume":"18","author":"Rocha","year":"2025","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neulet.2026.138746_b0010","doi-asserted-by":"crossref","unstructured":"K.A. Jellinger, Parkinson's disease, Neurodegeneration: the molecular pathology of dementia and movement disorders (2011) 194-223.","DOI":"10.1002\/9781444341256.ch21"},{"key":"10.1016\/j.neulet.2026.138746_b0015","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2026.138746_b0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/mds.27874","article-title":"Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease","volume":"35","author":"Haque","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2026.138746_b0025","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.3233\/JPD-223290","article-title":"Role of NLRP3 inflammasome in Parkinson\u2019s disease and therapeutic considerations","volume":"12","author":"Nguyen","year":"2022","journal-title":"J. Parkinson\u2019s Disease"},{"key":"10.1016\/j.neulet.2026.138746_b0030","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.2174\/0929867321666140915142809","article-title":"Development of EGFR family small molecule inhibitors for anticancer intervention: an overview of approved drugs and clinical candidates","volume":"21","author":"Cheng","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neulet.2026.138746_b0035","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4143\/crt.2023.1324","article-title":"Varlitinib and paclitaxel for EGFR\/HER2 co-expressing advanced gastric cancer: a multicenter phase Ib\/II study (K-MASTER-13)","volume":"56","author":"Koo","year":"2024","journal-title":"Cancer Res. Treatment: Official J. Korean Cancer Association"},{"key":"10.1016\/j.neulet.2026.138746_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.903309","article-title":"Inhibiting EGFR\/HER-2 ameliorates neuroinflammatory responses and the early stage of tau pathology through DYRK1A","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neulet.2026.138746_b0045","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12974-025-03461-z","article-title":"Rebamipide (Mucosta\u00ae), a clinically approved drug, alleviates neuroinflammation and dopaminergic neurodegeneration in a Parkinson\u2019s disease model","volume":"22","author":"Lim","year":"2025","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neulet.2026.138746_b0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bbrc.2012.04.013","article-title":"Juglans mandshurica leaf extract protects skin fibroblasts from damage by regulating the oxidative defense system","volume":"421","author":"Park","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neulet.2026.138746_b0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/brainsci10010032","article-title":"Inhibitory effects of myricetin on lipopolysaccharide-induced neuroinflammation","volume":"10","author":"Jang","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.neulet.2026.138746_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136667","article-title":"Resilin, an insect-derived elastomeric protein, protects dopaminergic neurons in Parkinson disease models","volume":"781","author":"Lim","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2026.138746_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115972","article-title":"Artemisinin protects dopaminergic neurons against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity in a mouse model of Parkinson\u2019s disease","volume":"170","author":"Lim","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neulet.2026.138746_b0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2020.07.010","article-title":"The insect molting hormone 20-hydroxyecdysone protects dopaminergic neurons against MPTP-induced neurotoxicity in a mouse model of Parkinson's disease","volume":"159","author":"Lim","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neulet.2026.138746_b0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","article-title":"Targeting HER2-positive breast cancer: advances and future directions","volume":"22","author":"Swain","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neulet.2026.138746_b0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbrc.2022.01.047","article-title":"Alpha-synuclein\/MPP+ mediated activation of NLRP3 inflammasome through microtubule-driven mitochondrial perinuclear transport","volume":"594","author":"Yang","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neulet.2026.138746_b0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.neulet.2026.138746_b0090","doi-asserted-by":"crossref","first-page":"12019","DOI":"10.2147\/DDDT.S576701","article-title":"Drug repurposing as an effective drug discovery strategy: a critical review","volume":"19","author":"Al Khzem","year":"2025","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.neulet.2026.138746_b0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394026002466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394026002466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:09:33Z","timestamp":1791140973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394026002466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":19,"alternative-id":["S0304394026002466"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2026.138746","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Varlitinib attenuates neuroinflammation and dopaminergic neurodegeneration in experimental Parkinsonism","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2026.138746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"138746"}}